Unit for glucose depletion

• US 9,647,289 B1
• Filed: 02/19/2014
• Issued: 05/09/2017
• Est. Priority Date: 02/19/2014
• Status: Expired due to Fees

• Current Assignee: Haskell Dighton, Patty Short
• Original Assignee: Haskell Dighton, Patty Short
• Inventors: Dighton, Haskell, Short, Patty
• Primary Examiner(s): Gilbert, Andrew
• Application Number:
  US14/184,428
• Time in Patent Office: 1,175 Days
• CPC Class Codes: A61N 1/205 for promoting a biological process
• CPC Class Codes: C12N 13/00 Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
• CPC Class Codes: C12Q 1/25 involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
• CPC Class Codes: G01N 33/721 Haemoglobin
• CPC Class Codes: H01M 8/16 Biochemical fuel cells, i.e. cells in which microorganisms function as catalysts
• CPC Class Codes: Y02E 60/50 Fuel cells

Abstract

The present invention relates to treating of multiple pathological conditions through controlled lowering of glucose levels in blood. The present invention further relates to devices capable of lowering glucose levels in blood by exposing blood to enzyme-treated pole.

Claims

1. A device for treating multiple pathological conditions through controlled lowering of glucose levels in blood, the device comprising:

a cavity comprising an inflow and outflow for blood products of the patient to be treated with the device to enter and exit the cavity, the cavity further comprising a first enzyme treated pole, the cavity further comprising a second enzyme treated pole of opposite polarity from the first pole, the first pole and second pole combining to break down glucose present in blood products of the patient into constituent elements including a flow of electrons,

a control circuit connecting the first and second pole,

a control panel capable of communicating with an inhibitor, the control panel comprising a selector for selecting a desired level of resistance to be applied to the control circuit,

the control panel receiving an initial signal from a first sensor of an initial level of glucose in the patient, applying a rate of glucose depletion through the selection of the desired level of resistance for the selector to slow down the flow of electrons generated from the breakdown of glucose in the patient'"'"'s blood products and thereby control the rate of glucose depletion of the patient'"'"'s blood products, the control panel setting a desired level of glucose in the blood products of the patient, the control panel receiving a second signal from a second sensor of a level of glucose present in the blood products of the patient after the glucose depletion of the patient'"'"'s blood products.

2. The device of claim 1, whereas the device is an external unit, the external unit comprising a display for selectively displaying a present level of glucose or a desired level of glucose.

3. The device of claim 1, whereby the device is an implant within the body of the patient.

4. The device of claim 1 further comprising an output for transmitting the flow of electrons.

5. The device of claim 4, whereby the output is a resistor.

6. The device of claim 1, whereby the enzyme in the first enzyme treated pole and the second enzyme treated pole is laccase.

7. A device for treating multiple pathological conditions through controlled lowering of a patient'"'"'s glucose levels in blood products, the device comprising

a cavity comprising an inflow and outflow for the blood products to enter and exit the cavity,

the cavity further comprising a first enzyme treated pole,

the cavity further comprising a second enzyme treated pole of opposite polarity from the first pole, the first pole and second pole combining to break down glucose present in blood products of the patient into constituent elements including a flow of electrons,

an inhibitor for applying resistance to the flow of electrons that results from treating the patient'"'"'s glucose levels, the inhibitor capable of slowing down the flow of electrons generated from the breakdown of glucose in the patient'"'"'s blood products,

a control panel communicating with the inhibitor, the control panel comprising a selector for manipulating a desired level of resistance to be applied to the flow of electrons the desired level of resistance being determined to balance the patient'"'"'s blood sugar level, the control panel receiving a signal from a sensor to input an initial glucose level and a signal from the selector to select the desired level of resistance to set a desired glucose level, whereby the desired level of resistance lowers the patient'"'"'s blood sugar level to the desired glucose level.